U.S., Jan. 14 -- ClinicalTrials.gov registry received information related to the study (NCT07336056) titled 'Nerivio Efficacy Under High-Frequency Use' on Jan. 09.
Brief Summary: This is a Post-marketing study investigating the impact of frequant usage with Nerivio on the safety profile of Remote Electrical Neuromodulation (REN) for the treatment of migraine.
This study assessed the safety and tolerability of REN when used at frequencies exceeding the labeled indication.
Study Start Date: Jan. 08
Study Type: INTERVENTIONAL
Condition:
Migraine
Intervention:
DEVICE: Nerivio (REN device)
Remote electrical neuromodulation (REN) device for the acute treatment of migraines. The device delivers transcutaneous electrical stimulation to the...